Revolution Medicines, Inc. (RVMD)
172.17
-4.18
(-2.37%)
USD |
NASDAQ |
Nov 13, 16:00
171.75
-0.42
(-0.24%)
After-Hours: 19:59
Revolution Medicines Price to Book Value : 15.50 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 15.88 |
| November 11, 2026 | 16.27 |
| November 10, 2026 | 17.38 |
| November 09, 2026 | 18.02 |
| November 06, 2026 | 17.31 |
| November 05, 2026 | 16.00 |
| November 04, 2026 | 17.98 |
| November 03, 2026 | 17.49 |
| November 02, 2026 | 16.94 |
| October 30, 2026 | 17.23 |
| October 29, 2026 | 17.13 |
| October 28, 2026 | 16.99 |
| October 27, 2026 | 16.77 |
| October 26, 2026 | 16.56 |
| October 23, 2026 | 16.84 |
| October 22, 2026 | 16.90 |
| October 21, 2026 | 17.49 |
| October 20, 2026 | 17.70 |
| October 19, 2026 | 16.40 |
| October 16, 2026 | 16.02 |
| October 15, 2026 | 17.04 |
| October 14, 2026 | 17.43 |
| October 13, 2026 | 16.97 |
| October 12, 2026 | 17.46 |
| October 09, 2026 | 17.09 |
| Date | Value |
|---|---|
| October 08, 2026 | 16.94 |
| October 07, 2026 | 18.09 |
| October 06, 2026 | 18.00 |
| October 05, 2026 | 18.70 |
| October 02, 2026 | 18.61 |
| October 01, 2026 | 18.54 |
| September 30, 2026 | 18.48 |
| September 29, 2026 | 16.81 |
| September 28, 2026 | 16.58 |
| September 25, 2026 | 16.85 |
| September 24, 2026 | 16.43 |
| September 23, 2026 | 15.68 |
| September 22, 2026 | 15.85 |
| September 21, 2026 | 15.85 |
| September 18, 2026 | 15.70 |
| September 17, 2026 | 16.19 |
| September 16, 2026 | 16.11 |
| September 15, 2026 | 16.84 |
| September 14, 2026 | 16.86 |
| September 11, 2026 | 16.75 |
| September 10, 2026 | 16.72 |
| September 09, 2026 | 17.07 |
| September 08, 2026 | 17.04 |
| September 04, 2026 | 17.26 |
| September 03, 2026 | 17.33 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 13.19 |
| Oncolytics Biotech, Inc. | -- |
| Intellia Therapeutics, Inc. | 2.220 |
| Twist Bioscience Corp. | 15.69 |
| Beam Therapeutics, Inc. | 2.481 |
Price to Book Value Related Metrics
| PS Ratio | 178.79 |
| PEG Ratio | -0.2503 |
| Price | 172.17 |
| Earnings Yield | -5.28% |
| Market Cap | 37.23B |
| PEGY Ratio | -0.2503 |